These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34452155)

  • 1. Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery.
    Scherließ R; Janke J
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
    Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
    Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate.
    Shiehzadeh F; Tafaghodi M; Dehghani ML; Mashhoori F; Fazly Bazzaz BS; Imenshahidi M
    Adv Pharm Bull; 2019 Jun; 9(2):255-261. PubMed ID: 31380251
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder formulation of azithromycin for COVID-19 therapeutics.
    Chan SHY; Sheikh K; Zariwala MG; Somavarapu S
    J Microencapsul; 2023 Jun; 40(4):217-232. PubMed ID: 36752024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
    Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
    Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA Ethionamide Nanoparticles for Pulmonary Delivery: Development and in vivo evaluation of dry powder inhaler.
    Debnath SK; Saisivam S; Omri A
    J Pharm Biomed Anal; 2017 Oct; 145():854-859. PubMed ID: 28826144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
    Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
    Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
    Lebhardt T; Roesler S; Uusitalo HP; Kissel T
    Eur J Pharm Biopharm; 2011 May; 78(1):90-6. PubMed ID: 21145394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
    Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.
    Thomas C; Gupta V; Ahsan F
    Pharm Res; 2010 May; 27(5):905-19. PubMed ID: 20232117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.